enVVeno Medical Corporati...

3.16
-0.11 (-3.36%)
At close: Jan 28, 2025, 1:57 PM

Company Description

enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases.

The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency.

Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg.

The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.

enVVeno Medical Corporation
enVVeno Medical Corporation logo
Country United States
IPO Date May 31, 2018
Industry Medical - Devices
Sector Healthcare
Employees 31
CEO Robert A. Berman

Contact Details

Address:
70 Doppler
Irvine, California
United States
Website https://www.envveno.com

Stock Details

Ticker Symbol NVNO
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001661053
CUSIP Number 29415J106
ISIN Number US29415J1060
Employer ID 33-0936180
SIC Code 3841

Key Executives

Name Position
Robert A. Berman Chief Executive Officer & Director
Craig Thomas Glynn Chief Financial Officer, Treasurer & Secretary
Dr. Hamed Alavi Ph.D. Senior Vice President & Chief Technology Officer
Andrew Cormack Chief Commercial Officer
Dr. Benedict Broennimann M.D. Chief Medical Officer of Outside of United States
Dr. Marc H. Glickman M.D. Senior Vice President & Chief Medical Officer
Sandy Prietto Vice President of Marketing
Warren Hancock Co-founder

Latest SEC Filings

Date Type Title
Jan 03, 2025 4 Filing
Jan 02, 2025 4 Filing
Dec 26, 2024 4 Filing
Dec 23, 2024 4 Filing
Dec 20, 2024 4 Filing
Dec 20, 2024 4 Filing
Dec 20, 2024 4 Filing
Dec 20, 2024 4 Filing
Dec 20, 2024 4 Filing
Dec 20, 2024 4 Filing